# Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women

> **NCT07466342** · PHASE4 · COMPLETED · sponsor: **Nishtar Medical University** · enrollment: 60 (actual)

## Conditions studied

- Dysmenorrhea Primary
- Vitamin E
- Mefenamic Acid

## Interventions

- **DRUG:** Mefenamic acid
- **DRUG:** Vitamin E capsule

## Key facts

- **NCT ID:** NCT07466342
- **Lead sponsor:** Nishtar Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-15
- **Primary completion:** 2026-01-14
- **Final completion:** 2026-01-14
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07466342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07466342, "Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07466342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*